CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Alibaba Health Information Technology Limited - 0241 CFD

2.62
1.16%
Market Trading Hours* (UTC) Open now
Closes on Monday at 04:00

Mon - Fri: 01:30 - 04:00 05:00 - 08:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022705 %
Charges from full value of position ($-4.31)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022705%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.000787 %
Charges from full value of position ($0.15)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.000787%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency HKD
Margin 5%
Stock exchange Hong Kong
Commission on trade 0%

*Information provided by Capital.com

Alibaba Health Information Technology Ltd ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 2.59
Open* 2.59
1-Year Change* -52.48%
Day's Range* 2.58 - 2.67
52 wk Range 3.15-7.89
Average Volume (10 days) 29.22M
Average Volume (3 months) 561.28M
Market Cap 51.82B
P/E Ratio 49.07
Shares Outstanding 13.53B
Revenue 30.67B
EPS 0.07
Dividend (Yield %) N/A
Beta 1.99
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 2.59 -0.01 -0.38% 2.60 2.63 2.57
Apr 18, 2024 2.62 0.00 0.00% 2.62 2.69 2.58
Apr 17, 2024 2.62 0.03 1.16% 2.59 2.64 2.58
Apr 16, 2024 2.60 -0.04 -1.52% 2.64 2.66 2.59
Apr 15, 2024 2.70 0.01 0.37% 2.69 2.74 2.65
Apr 12, 2024 2.73 -0.07 -2.50% 2.80 2.80 2.72
Apr 11, 2024 2.82 0.01 0.36% 2.81 2.83 2.71
Apr 10, 2024 2.86 0.00 0.00% 2.86 2.94 2.83
Apr 9, 2024 2.87 0.09 3.24% 2.78 2.90 2.76
Apr 8, 2024 2.79 -0.02 -0.71% 2.81 2.87 2.75
Apr 5, 2024 2.77 -0.12 -4.15% 2.89 2.90 2.77
Apr 3, 2024 2.94 -0.09 -2.97% 3.03 3.04 2.90
Apr 2, 2024 3.04 -0.19 -5.88% 3.23 3.29 3.03
Mar 28, 2024 3.16 0.08 2.60% 3.08 3.30 3.07
Mar 27, 2024 3.14 -0.01 -0.32% 3.15 3.18 3.11
Mar 26, 2024 3.21 0.03 0.94% 3.18 3.22 3.08
Mar 25, 2024 3.17 -0.06 -1.86% 3.23 3.23 2.99
Mar 22, 2024 3.26 -0.20 -5.78% 3.46 3.47 3.26
Mar 21, 2024 3.50 0.03 0.86% 3.47 3.53 3.40
Mar 20, 2024 3.37 0.01 0.30% 3.36 3.40 3.32

Alibaba Health Information Technology Limited Events

Time (UTC) Country Event
Friday, August 9, 2024

Time (UTC)

02:30

Country

HK

Event

Alibaba Health Information Technology Ltd Annual Shareholders Meeting
Alibaba Health Information Technology Ltd Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 26763 20577.6 15518.5 9596.48 5095.87
Revenue 26763 20577.6 15518.5 9596.48 5095.87
Cost of Revenue, Total 21061.7 16469.6 11901.2 7365.1 3764.6
Gross Profit 5701.33 4107.99 3617.25 2231.38 1331.26
Total Operating Expense 26217.6 20780.7 15076.4 9531.38 5127.09
Selling/General/Admin. Expenses, Total 2161.5 2376.49 1529.68 947.106 638.17
Research & Development 677.822 728.828 423.632 252.843 219.018
Interest Expense (Income) - Net Operating -454.218 -415.342 -309.776 -29.33 -51.304
Unusual Expense (Income) -60.21 -380.177 -82.196 -63.584 -12.432
Other Operating Expenses, Total 2830.99 2001.27 1613.83 1059.25 569.031
Operating Income 545.446 -203.079 442.081 65.091 -31.22
Interest Income (Expense), Net Non-Operating 5.548 -49.435 -40.862 -55.997 -29.61
Net Income Before Taxes 550.994 -252.514 401.219 9.094 -60.83
Net Income After Taxes 534.263 -265.941 342.68 -15.696 -91.764
Minority Interest -0.856 0.386 5.908 9.11 9.815
Net Income Before Extra. Items 533.407 -265.555 348.588 -6.586 -81.949
Net Income 533.407 -265.555 348.588 -6.586 -81.949
Income Available to Common Excl. Extra. Items 533.407 -265.555 348.588 -6.586 -81.949
Income Available to Common Incl. Extra. Items 533.407 -265.555 348.588 -6.586 -81.949
Diluted Net Income 533.407 -265.555 348.588 -6.586 -81.949
Diluted Weighted Average Shares 13541.6 13482.6 13326.5 11931.3 11055
Diluted EPS Excluding Extraordinary Items 0.03939 -0.0197 0.02616 -0.00055 -0.00741
Diluted Normalized EPS 0.03508 -0.03802 0.02095 -0.00402 -0.00814
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total revenue 15262.4 11500.6 11219.9 9357.71 8356.44
Revenue 15262.4 11500.6 11219.9 9357.71 8356.44
Cost of Revenue, Total 11861.8 9199.91 8982.68 7486.94 6599.5
Gross Profit 3400.68 2300.66 2237.22 1870.78 1756.93
Total Operating Expense 14894 11323.6 11218.2 9562.46 8279.28
Selling/General/Admin. Expenses, Total 1117.37 1032.62 1221.41 1158.93 881.62
Research & Development 353.836 323.986 406.078 322.75 194.183
Interest Expense (Income) - Net Operating -260.821 -156.512 -91.366 -548.078 -245.832
Unusual Expense (Income) -62.356 -1.021 -357.811 -23.723 -73.517
Other Operating Expenses, Total 1884.16 924.632 1057.25 1165.64 923.32
Operating Income 368.494 176.952 1.661 -204.74 77.159
Interest Income (Expense), Net Non-Operating 8.525 -2.977 -24.313 -25.122 -0.381
Net Income Before Taxes 377.019 173.975 -22.652 -229.862 76.778
Net Income After Taxes 372.287 161.976 -34.373 -231.568 64.126
Minority Interest 0.459 -1.315 0.589 -0.203 1.031
Net Income Before Extra. Items 372.746 160.661 -33.784 -231.771 65.157
Net Income 372.746 160.661 -33.784 -231.771 65.157
Income Available to Common Excl. Extra. Items 372.746 160.661 -33.784 -231.771 65.157
Income Available to Common Incl. Extra. Items 372.746 160.661 -33.784 -231.771 65.157
Diluted Net Income 372.746 160.661 -33.784 -231.771 65.157
Diluted Weighted Average Shares 13562.1 13521.1 13487.3 13477.9 13614.8
Diluted EPS Excluding Extraordinary Items 0.02748 0.01188 -0.0025 -0.0172 0.00479
Diluted Normalized EPS 0.02294 0.01181 -0.01975 -0.01834 0.00028
Dividends per Share - Common Stock Primary Issue 0 0
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 14913.8 13565.5 14199.7 5013 3303.39
Cash and Short Term Investments 10917.2 10547.9 11636.8 2997.47 2017.08
Cash 8941.31 8325.42 6419.69 2033.26
Cash & Equivalents 280.371
Short Term Investments 1975.86 2222.43 5217.08 964.204 1736.71
Total Receivables, Net 1279.34 1073.94 772.908 589.166 538.798
Accounts Receivable - Trade, Net 578.787 515.985 313.615 324.541 365.446
Total Inventory 2102.31 1550.15 1468.61 1217.26 595.793
Prepaid Expenses 464.7 330.447 310.423 148.867 150
Other Current Assets, Total 150.262 63.125 11.017 60.239 1.719
Total Assets 20747.6 19202 17739.2 7869.97 5981.88
Property/Plant/Equipment, Total - Net 68.548 165.106 52.289 72.332 8.886
Property/Plant/Equipment, Total - Gross 150.854 245.073 133.548 149.506 76.836
Accumulated Depreciation, Total -82.306 -79.967 -81.259 -77.174 -67.95
Goodwill, Net 810.853 810.853 54.576 54.576 27.006
Long Term Investments 4591.5 4303.86 3420.15 2703.87 2603.23
Note Receivable - Long Term 20.024 13.03 9.524 21.732 39.372
Other Long Term Assets, Total 33.831 17.39
Total Current Liabilities 5437.44 4822.13 3400.87 2609.9 3233.38
Accounts Payable 3714.05 3528.6 2551.55 1865.53 902.651
Accrued Expenses 176.064 169.815 105.73 59.645 56.518
Notes Payable/Short Term Debt 0 0 0 0 1700
Other Current Liabilities, Total 1509.9 1073.06 723.258 652.702 574.213
Total Liabilities 5573.85 5103.55 3437.25 2600.83 3187.37
Total Long Term Debt 40.361 84.758 17.406 37.725 0
Long Term Debt 0
Deferred Income Tax 122.417 116.483 39.322 19.829 11.677
Minority Interest -26.374 -26.187 -20.346 -66.63 -57.693
Total Equity 15173.7 14098.4 14302 5269.15 2794.52
Common Stock 119.133 119.102 118.859 106.108 102.898
Additional Paid-In Capital 43734.1 43499.9 43281.3 22344.7 20044.2
Retained Earnings (Accumulated Deficit) -28706 -29261.2 -29031.4 -17571.6 -17635.3
Treasury Stock - Common -70.482 -23.516 -22.265 -13.039 -25.052
ESOP Debt Guarantee 477.237 460.077 363.949 210.73 231.955
Other Equity, Total -380.919 -724.479 -452.462 150.697 75.873
Total Liabilities & Shareholders’ Equity 20747.6 19202 17739.2 7869.97 5981.88
Total Common Shares Outstanding 13521.4 13505.2 13475.4 12061.6 11698.3
Intangibles, Net 309.01 326.215 2.935 4.467
Current Port. of LT Debt/Capital Leases 37.437 50.656 20.334 32.03
Capital Lease Obligations 40.361 84.758 17.406 37.725
Unrealized Gain (Loss) 0.613 28.529 43.971 41.545
Other Liabilities, Total 0 106.363
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Total Current Assets 14913.8 14575.7 13565.5 14626.1 14199.7
Cash and Short Term Investments 10917.2 11255 10547.9 11283.1 11636.8
Cash & Equivalents 10917.2 11255 10547.9 11256.5 11636.8
Short Term Investments 26.68 0
Total Receivables, Net 578.787 533.094 515.985 505.028 313.615
Accounts Receivable - Trade, Net 578.787 533.094 515.985 505.028 313.615
Total Inventory 2102.31 1608.81 1550.15 1759.7 1468.61
Prepaid Expenses 1165.26 1074.65 888.4 1074.74 769.716
Other Current Assets, Total 150.262 104.12 63.125 3.541 11.017
Total Assets 20747.6 20322.5 19202 19658.2 17739.2
Property/Plant/Equipment, Total - Net 68.548 79.463 165.106 93.769 52.289
Goodwill, Net 810.853 810.853 810.853 845.305 54.576
Intangibles, Net 309.01 317.125 326.215 335.526 2.935
Long Term Investments 4591.5 4499.12 4303.86 3747.42 3420.15
Note Receivable - Long Term 20.024 24.215 13.03 10.07 9.524
Total Current Liabilities 5437.44 5229.32 4822.13 5352.25 3400.87
Accounts Payable 3714.05 3750.4 3528.6 4233.63 2551.55
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 37.437 36.045 50.656 25.423 20.334
Other Current Liabilities, Total 1685.96 1442.88 1242.88 1093.2 828.988
Total Liabilities 5573.85 5378.2 5103.55 5584.21 3437.25
Total Long Term Debt 40.361 52.188 84.758 42.404 17.406
Capital Lease Obligations 40.361 52.188 84.758 42.404 17.406
Deferred Income Tax 122.417 116.107 116.483 114.226 39.322
Minority Interest -26.374 -25.838 -26.187 -25.564 -20.346
Total Equity 15173.7 14944.3 14098.4 14074 14302
Common Stock 119.133 119.122 119.102 118.875 118.859
Additional Paid-In Capital 43734.1 43674.9 43499.9 43399.4 43281.3
Retained Earnings (Accumulated Deficit) -28706 -29093 -29261.2 -29254.8 -29031.4
Treasury Stock - Common -70.482 -11.549 -23.516 -32.596 -22.265
ESOP Debt Guarantee 477.237 416.542 460.077 419.61 363.949
Unrealized Gain (Loss) 0.613 9.688 28.529 44.228 43.971
Other Equity, Total -380.919 -171.453 -724.479 -620.675 -452.462
Total Liabilities & Shareholders’ Equity 20747.6 20322.5 19202 19658.2 17739.2
Total Common Shares Outstanding 13521.4 13520.1 13505.2 13477.3 13475.4
Other Liabilities, Total 0 6.424 106.363 100.887
Other Long Term Assets, Total 33.831 16.013 17.39
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Net income/Starting Line -252.514 401.219 9.094 -60.83
Cash From Operating Activities 255.69 424.363 1009.43 583.615 396.37
Cash From Operating Activities 48.671 31.062 33.125 3.989
Non-Cash Items -247.119 178.196 265.003 168.324
Cash Taxes Paid 45.336 27.897 8.535 19.264
Cash Interest Paid 3.815 2.449 39.294 10.624
Changes in Working Capital 255.69 863.42 396.937 274.916 284.887
Cash From Investing Activities -532.436 1872.31 -4961.48 1345.39 -2395.71
Capital Expenditures -15.115 -17.558 -13.511 -6.102
Other Investing Cash Flow Items, Total -532.436 1887.42 -4943.93 1358.9 -2389.61
Cash From Financing Activities -111.278 -58.628 8922.41 328.814 1708.49
Financing Cash Flow Items -111.278 -4.79 -0.11 -36.161 -10.624
Issuance (Retirement) of Stock, Net -6.826 8954.13 2094.75 19.113
Issuance (Retirement) of Debt, Net -47.012 -31.616 -1729.77 1700
Foreign Exchange Effects 283.447 -148.891 -313.057 56.796 62.804
Net Change in Cash -104.577 2089.15 4657.29 2314.61 -228.048
Amortization 11.905 2.013 1.477
Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
Net income/Starting Line 173.975 -252.514 -229.862 401.219
Cash From Operating Activities 255.69 504.049 424.363 597.704 1009.43
Cash From Operating Activities 26.783 48.671 20.594 31.062
Amortization 9.114 11.905 2.465 2.013
Non-Cash Items 106.416 -247.119 -114.38 178.196
Cash Taxes Paid 18.507 45.336 40.699 27.897
Cash Interest Paid 3.362 3.815 0.737 2.449
Changes in Working Capital 255.69 187.761 863.42 918.887 396.937
Cash From Investing Activities -532.436 -736.551 1872.31 1341.08 -4961.48
Capital Expenditures -4.777 -15.115 -6.834 -17.558
Other Investing Cash Flow Items, Total -532.436 -731.774 1887.42 1347.91 -4943.93
Cash From Financing Activities -111.278 -16.01 -58.628 -20.816 8922.41
Financing Cash Flow Items -111.278 0 -4.79 -4.79 -0.11
Issuance (Retirement) of Stock, Net 8.185 -6.826 6.2 8954.13
Issuance (Retirement) of Debt, Net -24.195 -47.012 -22.226 -31.616
Foreign Exchange Effects 283.447 309.91 -148.891 -123.909 -313.057
Net Change in Cash -104.577 61.398 2089.15 1794.06 4657.29

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Alibaba Health Company profile

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People's Republic of China. The company engages in the B2C pharmacy business that provides outsourced and value-added services, and other related services to the Tmall entities, and centralized procurement and distribution businesses. It also operates Drug PIATS, a product identification, authentication, and tracking system for the drug industry; and a medical services network, as well as offers online health consultation services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. It has strategic collaboration agreement with Merck KGaA to develop patient-centric digital services. The company is based in Causeway Bay, Hong Kong. Alibaba Health Information Technology Limited is a subsidiary of Perfect Advance Holding Limited.
Industry: Internet & Mail Order Department Stores

銅鑼灣勿地臣街1號時代廣場1座26樓
HK

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

ETH/USD

3,147.60 Price
-0.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

17,096.70 Price
+0.390% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

64,818.75 Price
-0.010% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.53 Price
-0.450% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading